SDC1 and breast carcinoma: Moreover, both cell lines represented distinct subtypes of breast cancer (luminal vs. basal), different stages of dedifferentiation (epithelial vs. mesenchymal morphology), and distinct levels of syndecan-1 expression and were thus considered suitable for evaluating the syndecan-1-dependent functions of the tissue factor pathway in different subtypes of breast cancer.